Hidemaru Yamaguchi
Stock Analyst at Citi
(0.99)
# 3,694
Out of 4,421 analysts
62
Total ratings
45.2%
Success rate
-2.8%
Average return
Main Sectors:
Stocks Rated by Hidemaru Yamaguchi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TYO: 4506 Sumitomo Pharma Co., Ltd. | Maintained: Sell | ¥1,260 → ¥1,500 | $1,469.50 | +2.08% | 5 | May 25, 2026 | |
| TYO: 4503 Astellas Pharma Inc. | Maintained: Hold | ¥2,500 → ¥2,400 | $2,145.50 | +11.86% | 3 | May 1, 2026 | |
| TYO: 2503 Kirin Holdings Company, Limited | Downgraded: Hold | ¥2,800 | $2,772.50 | +0.99% | 1 | Apr 3, 2026 | |
| TYO: 4587 PeptiDream Inc. | Downgraded: Hold | ¥3,300 → ¥1,600 | $959.80 | +66.70% | 2 | Mar 12, 2026 | |
| TYO: 4151 Kyowa Kirin Co., Ltd. | Downgraded: Sell | ¥3,800 → ¥2,000 | $2,537.50 | -21.18% | 2 | Mar 10, 2026 | |
| TYO: 2413 M3, Inc. | Maintained: Buy | ¥2,600 → ¥2,800 | $1,637.50 | +70.99% | 6 | Feb 9, 2026 | |
| TYO: 4568 Daiichi Sankyo Company, Limited | Maintained: Buy | ¥5,800 → ¥4,900 | $2,541.50 | +92.80% | 6 | Feb 5, 2026 | |
| TYO: 4552 JCR Pharmaceuticals Co., Ltd. | Maintained: Hold | ¥600 → ¥670 | $457.00 | +46.61% | 4 | Feb 5, 2026 | |
| TYO: 4565 Nxera Pharma Co., Ltd. | Maintained: Buy | ¥1,100 → ¥1,400 | $959.00 | +45.99% | 5 | Nov 28, 2025 | |
| TYO: 4523 Eisai Co., Ltd. | Maintained: Buy | ¥5,900 → ¥6,200 | $3,902.00 | +58.89% | 5 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥3,800 → ¥3,900 | $2,224.50 | +75.32% | 2 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥3,200 → ¥3,500 | $3,492.00 | +0.23% | 2 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ¥1,750 | $2,249.00 | -22.19% | 1 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥10,400 → ¥10,500 | $10,515.00 | -0.14% | 3 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥5,100 → ¥4,600 | $3,972.00 | +15.81% | 3 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥2,600 | $1,874.00 | +38.74% | 1 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥4,200 → ¥3,500 | $3,690.00 | -5.15% | 2 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ¥2,410 | $2,591.50 | -7.00% | 1 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ¥960 | $1,043.00 | -7.96% | 1 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | ¥2,600 | $2,294.00 | +13.34% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥12,000 | $7,550.00 | n/a | 1 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥3,100 → ¥2,800 | $2,780.00 | n/a | 2 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ¥3,300 | $1,364.00 | n/a | 1 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $30.11 | n/a | 1 | Mar 29, 2010 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $25.23 | n/a | 1 | Nov 18, 2009 |
Sumitomo Pharma Co., Ltd.
May 25, 2026
Maintained: Sell
Price Target: ¥1,260 → ¥1,500
Current: $1,469.50
Upside: +2.08%
Astellas Pharma Inc.
May 1, 2026
Maintained: Hold
Price Target: ¥2,500 → ¥2,400
Current: $2,145.50
Upside: +11.86%
Kirin Holdings Company, Limited
Apr 3, 2026
Downgraded: Hold
Price Target: ¥2,800
Current: $2,772.50
Upside: +0.99%
PeptiDream Inc.
Mar 12, 2026
Downgraded: Hold
Price Target: ¥3,300 → ¥1,600
Current: $959.80
Upside: +66.70%
Kyowa Kirin Co., Ltd.
Mar 10, 2026
Downgraded: Sell
Price Target: ¥3,800 → ¥2,000
Current: $2,537.50
Upside: -21.18%
M3, Inc.
Feb 9, 2026
Maintained: Buy
Price Target: ¥2,600 → ¥2,800
Current: $1,637.50
Upside: +70.99%
Daiichi Sankyo Company, Limited
Feb 5, 2026
Maintained: Buy
Price Target: ¥5,800 → ¥4,900
Current: $2,541.50
Upside: +92.80%
JCR Pharmaceuticals Co., Ltd.
Feb 5, 2026
Maintained: Hold
Price Target: ¥600 → ¥670
Current: $457.00
Upside: +46.61%
Nxera Pharma Co., Ltd.
Nov 28, 2025
Maintained: Buy
Price Target: ¥1,100 → ¥1,400
Current: $959.00
Upside: +45.99%
Eisai Co., Ltd.
Sep 12, 2025
Maintained: Buy
Price Target: ¥5,900 → ¥6,200
Current: $3,902.00
Upside: +58.89%
Aug 29, 2025
Maintained: Buy
Price Target: ¥3,800 → ¥3,900
Current: $2,224.50
Upside: +75.32%
Aug 29, 2025
Maintained: Buy
Price Target: ¥3,200 → ¥3,500
Current: $3,492.00
Upside: +0.23%
Aug 28, 2025
Maintained: Hold
Price Target: ¥1,750
Current: $2,249.00
Upside: -22.19%
Aug 27, 2025
Maintained: Buy
Price Target: ¥10,400 → ¥10,500
Current: $10,515.00
Upside: -0.14%
Aug 26, 2025
Maintained: Buy
Price Target: ¥5,100 → ¥4,600
Current: $3,972.00
Upside: +15.81%
Aug 22, 2025
Maintained: Buy
Price Target: ¥2,600
Current: $1,874.00
Upside: +38.74%
Aug 22, 2025
Maintained: Buy
Price Target: ¥4,200 → ¥3,500
Current: $3,690.00
Upside: -5.15%
Jun 26, 2025
Maintained: Hold
Price Target: ¥2,410
Current: $2,591.50
Upside: -7.00%
Jun 26, 2025
Maintained: Hold
Price Target: ¥960
Current: $1,043.00
Upside: -7.96%
Jun 24, 2025
Downgraded: Hold
Price Target: ¥2,600
Current: $2,294.00
Upside: +13.34%
May 27, 2025
Maintained: Buy
Price Target: ¥12,000
Current: $7,550.00
Upside: n/a
May 21, 2025
Maintained: Buy
Price Target: ¥3,100 → ¥2,800
Current: $2,780.00
Upside: n/a
Nov 26, 2024
Maintained: Hold
Price Target: ¥3,300
Current: $1,364.00
Upside: n/a
Mar 29, 2010
Upgraded: Buy
Price Target: n/a
Current: $30.11
Upside: n/a
Nov 18, 2009
Upgraded: Hold
Price Target: n/a
Current: $25.23
Upside: n/a